How to assess sympathetic activity in humans

Journal of Hypertension

Volumn 17, Issue 6, 1999, Pages 719-734

  Grassi, Guido ^a,c   Esler, Murray ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c Ctro Fisiol Clinica e Ipertensione   (Italy)

Author keywords

Adrenaline; Heart failure; Hypertension; Imaging techniques; Microneurography; Noradrenaline; Noradrenaline spillover; Power spectral analysis; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR; NORADRENALIN; TRACER;

ADRENERGIC SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DISEASE COURSE; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART INFARCTION; HEART RATE; HOMEOSTASIS; HUMAN; METABOLISM; NEUROGRAPHY; NORADRENALIN BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0033024752     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917060-00001     Document Type: Review

References (170)

1. 1 Cyon E, DE, Ludwig C. Die Reflexe eines der sensiblen nerven des herzens auf die motorischen der blutgefässe. Ber Sachs Ges Akad Wiss 1866; 18:307-328.
2. 2 Pavlov IP. Über den einfluss des vagus auf die arbeit der linkem herzkammer. Arch Anat Physiol 1887; 452-468.
3. 3 Shepherd JT, Mancia G. Reflex control of the human cardiovascular system. Rev Physiol Biochem Pharmacol 1986; 105:1-99.
4. 4 Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985; 60:1210-1215.
5. 5 Lakatta EG. cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73:413-467.
6. 6 Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Bannister R, Mathias CJ (editors): Autonomic failure. Oxford: Oxford University Press; 1992, pp. 255-290.
7. 7 Esler M, Jennings G, Korner P, Willett J, Dudley F, Hasking G, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11:3-20.
8. 8 Mancia G. Björn Folkow award lecture. The sympathetic nervous system in hypertension. J Hypertens 1997; 15:1553-1565.
9. 9 Grassi G, Cattaneo BM, Mancia G. sympathetic nervous system. In: Poole-Wilson PA, Colucci WS, Massie BM, Chattergee K, Coats AJ (editors): Heart failure: scientific principles and clinical practice. New York: Churchill Livingstone; 1997, pp. 199-214.
10. 10 Rouleau JL, Moje LA, De Champlain J, Klein M, Bichet D, Packer M, et al. Activation of neurohumoral systems following acute myocardial infarction. Am J Cardiol 1992; 68:80D-86D.
11. 11 Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294:1165-1170.
12. 12 Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325:618-624.
13. 13 Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens 1996; 14 (Suppl. 5):S159-S165.
14. 14 Mancia G, Saino A, Grassi G. Interactions between the sympathetic nervous system and the renin angiotensin system. In: Laragh J, Brenner B (editors): Hypertension: pathophysiology, diagnosis and management. New York: Raven Press; 1995, pp. 399-407.
15. 15 Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone. Circulation 1997; 96:4104-4113.
16. 16 Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens 1998; 16:1979-1987.
17. 17 Landsberg L, Krieger OR. Obesity, metabolism and the sympathetic nervous system. Am J Hypertens 1989; 2 (Suppl. 2): 125s-132s.
18. 18 Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
19. 19 Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med 1991; 114:373-380.
20. 20 Cohn JN, Levine TB, Olivari MT, Garber V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
21. 21 Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamines response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 1981; 102:24-29.
22. 22 Brod J, Fencl V, Hejl Z, Jirka J. Circulatory changes underlying blood pressure elevation during acute emotional stress in normotensive and hypertensive subjects. Clin Sci 1959; 18:269-279.
23. 23 Thomas CD, Stanley JA, Kendrick MA. Observations on some possible precursors of essential hypertension and coronary artery disease: the subjective reaction to cold pressor test as expressed in the verbal response. J Chron Dis 1961; 14:355-362.
24. 24 Lundin S, Jern S, Hansson L. Testing neural control of circulation in patients: hemodynamic responses to exercise and stressful stimuli. In: Zanchetti A, Tarazi RC (editors): Handbook of hypertension,: pathology of hypertension, regulatory mechanisms (volume 8). Amsterdam: Elsevier Science; 1986, pp. 237-249.
25. 25 Parati G, Pomidossi G, Ramirez AJ, Cesana B, Mancia G. Variability of the haemodynamic responses to laboratory tests employed in assessment of neural cardiovascular regulation in man. Clin Sci 1985; 69:533-540.
26. 26 Parati G, Pomidossi G, Casadei R, Ravogli A, Groppelli A, Cesana B, et al. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens 1988; 6:481-488.
27. 27 Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-503.
28. 28 Levy MN, Martin PJ. Autonomic control of cardiac conduction and automaticity. In: Shepherd JT, Vatner SF (editors): Nervous control of the heart. Amsterdam: Harwood Academic Publishers; 1996, pp. 201-226.
29. 29 Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R, et al. Heart rate as marker of sympathetic activity. J Hypertens 1998; 16:1635-1639.
30. 30 Julius S, Pascual AV, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971; 44:413-418.
31. 31 Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, et al. Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators. Medicine (Baltimore) 1975; 54:29-55.
32. 32 Egan B, Panis R, Hinderuter A, Shork N, Julius S. Mechanisms of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80:182-186.
33. 33 Doyle AE, Smirk FH. The neurogenic component in hypertension. Circulation 1955; 12:543-552.
34. N-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension 1998; 32:101-107.
35. 35 Hoeldtke RD, Cilmi KM, Reichard GA, Boden G, Owen OE. Assessment of norepinephrine secretion and production. J Lab Clin Med 1983; 101:772-782.
36. 36 Kopin IJ. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 1985; 37:333-365.
37. 37 Robertson D, Johnson GA, Robertson RM, Neis AS, Shand DG, Oates JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979; 59:637-643.
38. 38 Mailing TJB, Dollery CT, Hamilton CA. Clonidine and sympathetic activity during sleep. Clin Sci 1979; 57:509-514.
39. 39 Hjemdahl P. Inter-laboratory comparison of plasma catecholamine determinations using several different assays. Acta Physiol Scand 1984; 112 (Suppl. 527):43-54.
40. 40 Grassi G, Bolla GB, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 1997; 92:285-289.
41. 41 Hjemdahl P. Plasma catecholamines: analytical challenges and physiological limitations. Clin Endocrinol Metab 1993; 7:307-353.
42. 42 Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols urinary high-performance liquid chromatography with electrochemical detection. J Chromat 1994; 653:131-138.
43. 43 Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73:615-621.
44. 44 Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92:3206-3211.
45. 45 Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25:560-563.
46. 46 Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983; 5:86-89.
47. 47 Young JB, McDonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992; 16:959-967.
48. 48 Esler MD, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamines neurotransmitters to the circulation: source, late and functions. Physiol Rev 1990; 70:963-985.
49. 49 Halter JB, Pflug AE, Tolas AG. Arterial-venous difference of plasma catecholamines in man. Metabolism 1980; 29:9-12.
50. 50 Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension 1992; 19:628-633.
51. 51 Folkow B, Di Bona GF, Hjemdahl P, Thoren PH, Wallin BG. measurements of plasma norepinephrine concentrations in human primary hypertension. Hypertension 1983; 5:398-403.
52. 52 Lambert GW, Kaye DM, Thompson JM, Turner AG, Ferrier C, Cox HS et al. Catecholamine metabolites in internal jugutar veins: a window into the human brain. In: Goldstein DS, Eisenhofer G, McCarty R (editors): Catecholamines: bridging basic science with clinical medicine. San Diego: Academic Press; 1998, pp. 364-366.
53. 53 Kopin IJ, Rundqvist B, Friberg P, Lenders J, Goldstein DS, Eisenhofer G. Different relationships of spillover to release of norepinephrine in human heart, kidneys and forearm. Am J Physiol 1998; 275:R165-R173.
54. 54 Meredith IT, Eisenhofer G, Lambert GW, Dewar EMN, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993; 88:136-145.
55. 55 Kaye DM, Esler MD, Kingwell B, Jennings JL, McPherson G, Esmore D. Functional and neurochemical evidence of partial cardiac sympathetic reinnervation after cardiac transplantation. Circulation 1993; 88:1110-1118.
56. 56 Vallbo A, Hagbarth KE, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59:919-957.
57. 57 Delius W, Hagbarth KE, Hongell A, Wallin BG. General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand 1972; 84:65-81.
58. 58 Hagbarth KE, Hallin RG, Hongell A, Torebjork HE, Wallin BG. General characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand 1972; 84:177-186.
59. 59 Sugenoya J, Iwase S, Mano T, Sugiyama Y, Ogawa T, Nishiyama T, et al. Vasodilator component in sympathetic nerve activity destined for the skin of the dorsal foot of mildly heated humans. J Physiol (Lond) 1998; 507:603-610.
60. 60 Eckberg DL, Wallin BG, Fagius J, Lundberg L, Torebjörk HE. Prospective study of symptoms after human microneurography. Acta Physiol Scand 1989; 137:567-569.
61. 61 Anderson EA, Wallin BG, Mark AL. Dissociation of sympathetic nerve activity to arm and leg during mental stress. Hypertension 1987; 9 (Suppl. III):114-119.
62. 62 Sundlof G, Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol (Lond) 1977; 272:383-397.
63. 63 Fagius J, Wallin BG. Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 1993; 3:201-205.
64. 64 Lambert GW, Thompson JH, Turner AG, Cox HS, Wilkinson D, et al. Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy subjects. J Auton Nerv Syst 1997; 64:57-64.
65. 65 Wallin BG, Esler MD, Dorward P, Eisenhofer G, Ferrier C, Westorman R, et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (Lond) 1992; 453:45-58.
66. 66 Wallin BG, Thompson JH, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (Lond) 1996; 491:881-887.
67. 67 Macefield VG, Wallin BG, Vallbo AB. The discharge behaviour of single vasoconstrictor motor neurones in human muscle nerves. J Physiol (Lond) 1994; 481:799-809.
68. 68 Greenwood JP, Stoker JB, Walker JJ, Mary DA. Sympathetic nerve discharge in normal pregnancy and in pregnancy-induced hypertension. J Hypertens 1998; 16:617-624.
69. 69 Greenwood JP, Stoker JB, Mary DASG. Peripheral sympathetic neural discharge from recordings of single unit activity in patients with established hypertension [Abstract]. J Hypertens 1998; 16 (Suppl. 2):S33.
70. 70 Brown GL, Gillespie JS. The output of sympathetic transmitter from the spleen of the cat. J Physiol (Lond) 1957; 138:81-102.
71. 71 Bradley T, Hjemdahl P. Renal extraction of endogenous and radiolabelled catecholamines in the dog. Acta Physiol Scand 1986; 122:369-379.
72. 72 Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, et al. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 1979; 25:1461-1470.
73. 73 Esler M, Jennings G, Korner P, Blombery P, Sacharìas N, Leonard P. Measurements of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984; 247:E21-E28.
74. 74 Henriksen JH, Christensen NJ. Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearanco. Am J Physiol 1989; 257:E743-E750.
75. 75 Eisenhofer G, Esler M, Goldstein DS, Kopin IJ. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of it plasma kinetics. Am J Physiol 1991; 261:E505-E515.
76. 76 Esler MD, Wallin BG, Dorward PK, Eisenhofer R, Westerman I, Meredith I, et al. Effect of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 1991; 260:R817-R823.
77. 77 Chang PG, Krogt JA, Van Brummelen P. Demonstration of neuronal and extraneuronal uptake of circulating norepinephrine in the forearm. Hypertension 1987; 9:647-653.
78. 78 Cousineau D, Goresky CA, Bach GC, Rose CP. Effect of β-adrenergic blockade on in vivo norepinephrine release in canine heart. Am J Physiol 1984; 246:H283-H292.
79. 79 Axelrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985; 249:H867-H875.
80. 80 Malliani A, Pagani M, Lombardi F, Cerutti S. cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84:482-492.
81. 81 Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. heart rate spectral analysis, cardiac norepinephrine spillover and muscle sympathetic nerve activity during sympathetic nervous activation and failure. Circulation 1994; 90:234-240.
82. 82 Manhem P, Lacerof H, Hokfert B. Plasma catecholamine levels in the coronary sinus, the left renal vein and peripheral vessels in healthy males at rest and during exercise. Acta Physiol Scand 1978; 104:364-369.
83. 83 Hasking GL, Esler MD, Jennings GL, Dewar E, Lambert G. Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation 1988; 78:516-521.
84. 84 Saito M, Mano T, Iwase S. Sympathetic nerve activity related to local fatigue sensation during static contraction. J Appl Physiol 1989; 67:980-984.
85. 85 Esler MD, Jennings G, Lambert G. Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneurology 1989; 14:477-481.
86. 86 Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen KUO, et al. Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation 1997; 96:2509-2513.
87. 87 Victor RG, Seals DR, Mark AL. Differential control of heart rate and sympathetic nerve activity during dynamic exercise. J Clin Invest 1987; 79:508-516.
88. 88 Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve response to static exercise in humans. Circ Res 1985; 57:461-469.
89. 89 Wallin BG, Sundlof G. Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 1982; 6:287-291.
90. 90 Arai Y, Saul JP, Albrecht P, Hartley LH, Lilly LS, Cohen RJ, et al. Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol 1989; 256:H132-H141.
91. 91 Kingwell BA, Thompson JM, McPherson GA, Kaye DM, Jennings GL, Esler MD. Comparison of heart rate spectral analysis with cardiac noradrenaline spillover and muscle sympathetic nerve activity in human subjects. In: Di Rienzo M, Mancia G, Parati G, Pedotti A, Zanchetti A (editors): Computer analysis of cardiovascular signals. Amsterdam: IOS Press; 1995, pp. 167-176.
92. 92 Hoshikawa Y, Yamamoto Y. Effects of stroop color-word conflict test on the autonomic nervous system responses. Am J Physiol 1997; 272:H1113-H1121.
93. 93 Pagani M, Mazzuero G, Ferrari A, Liberati D, Cerutti S, Vaitl D, et al. Sympathovagal interaction during mental stress: a study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation 1993; 83 (Suppl. II):43-51.
94. 94 Lipsitz LA, Ryan SM, Parker JA, Freeman R, Wei JY, Goldberger AL. Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation 1993; 87:391-400.
95. 95 Boulos M, Barron S, Nicolski E, Markiewicz W. Power spectral analysis of heart rate variability during upright tilt test: a comparison of patients with syncope and normal subjects. Cardiology 1996; 87:28-32.
96. 96 Esler MD, Thompson JM, Kaye DM, Turner AG, Jennings GL, Cox HS, et al. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995; 91:351-358.
97. 97 Esler M, Dudley F, Jennings G, Debinski H, Lambert G, Jones P, et al. Increased sympathetic nervous activity and effects of its pharmacological inhibition in alcoholic cirrhosis. Ann Intern Med 1992; 116:446-455.
98. 98 Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in essential hypertension. Clin Exp Hypertens 1989; 11 (Suppl. 1):75-89.
99. 99 Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21:498-503.
100. 100 Matsukawa T, Sugiyama Y, Watanabe T, Kobayashi F, Mano T. Baroreflex control of muscle sympathetic nerve activity is attenuated in the elderly. J Auton Nerv Syst 1998; 73:182-185.
101. 101 Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73:913-919.
102. 102 Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989; 14:177-183.
103. 103 Rea R, Hamdan M. Baroreflex control of muscle sympathetic nerve activity in borderline hypertension. Circulation 1990; 82:856-862.
104. 104 Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 1993; 11:647-655.
105. 105 Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest 1993; 92:25-28.
106. 106 Grassi G, Cattanco BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31:68-72.
107. 107 Yamada Y, Miyajima E, Tochikubo O, Matsukawa AT, Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13:870-877.
108. 108 Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986; 59:178-193.
109. 109 Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988; 61:1292-1299.
110. 110 Ando SI, Dajani HR, Floras JS. Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans. Am J Physiol 1997; 273:R205-R212.
111. 111 Van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997; 95:1449-1454.
112. 112 Laffi G, Lagi A, Cipriani M, Barletta G, Bernardi L, Fattorini L, et al. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 1996; 24:1063-1067.
113. 113 Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, et al. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 1988; 6:711-717.
114. 114 Aono T, Sato T, Nishinaga M, Kawamoto A, Ozawa T. Power spectral analysis of spontaneous blood pressure and heart rate variability in the elderly hypertensives. Hypertens Res 1996; 19:9-16.
115. 115 Kohara K, Igase M, Maguchi M, Fukuoka T, Kitami Y, Hiwada K. Autonomic nervous function in essential hypertension in the elderly. Evaluation by power spectral analysis of heart rate variability. Am J Hypertens 1996; 9:1084-1089.
116. 116 Montano N, Gnecchi Ruscone T, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994; 90:1826-1831.
117. 117 Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart failure variability in evaluating cardiovascular regulation. Hypertension 1995; 25:1276-1286.
118. 118 Mancia G, Daffonchio A, Di Rienzo M, Ferrari AU, Grassi G. Methods to quantify sympathetic cardiovascular influences. Eur Heart J 1998; 19:F7-F13.
119. 119 Eckberg DL. Spectral balance: a critical appraisal. Circulation 1997; 96:3224-3232.
120. 120 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Circulation 1996; 93:1043-1065.
121. 121 Goldstein DS. Clinical assessment of catecholaminergic function. In: Goldstein DS (editor): Stress, catecholamines and cardiovascular disease. New York: Oxford University Press; 1995, pp. 234-286.
122. 122 Goldstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 1990; 81:1606-1621.
123. 18F] fluorodopamine: initial findings in humans. J Am Coll Cardiol 1993; 22:1961-1971.
124. 124 Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336:696-702.
125. 125 Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997; 336:1208-1215.
126. 126 Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993; 22:368-375.
127. 18F] fluorodopamine positron emission tomography (PET) scanning in the assessment of cardiac sympathoneuronal function. Clin Auton Res 1997; 7:17-29.
128. 128 Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvers affecting sympathetic outflow in human skin nerves. Acta Physiol Scand 1972; 84:177-186.
129. 129 Tidgren B, Hjemdahl P. Renal response to mental stress and epinephrine in humans. Am J Physiol 1989; 257:F682-F689.
130. 130 Hjemdahl P, Freyschuss U, Juhlin-Dannfeldt J, Linde B. Differentiated sympathetic activation during mental stress evoked by the Stroop-test. Acta Physiol Scand 1984; 121 (Suppl. 527):25-29.
131. 131 Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J. Renal responses to lower body negative pressure in humans. Am J Physiol 1990; 259;F253-F257.
132. 132 Grassi G, Seravalle G, Calhoun DA, Bolla GB, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90:248-253.
133. 133 Narkiewicz K, Van de Borne PJH, Hausberg M, Cooley RL, Winniford MD, Davison DE, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98:528-534.
134. 134 Esler MD, Meredith I. Responses of the human sympathetic nervous system to stressors. In: Shepherd KE, Boublik JH, Funder JW (editors): Stress and reproduction. ARES Symposium Publication No. 86. New York: Raven Press; 1992, pp. 19-30.
135. 135 Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Hypertension 1989; 14:177-183.
136. 136 Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Bolla GB, Mancia G. baroreflex impairment by low sodium diet in mild or moderate essential hypertension. Hypertension 1997; 29:802-807.
137. 137 Friberg P, Mereredith I, Jennings G, Lambert G, Fazio V, Esler M. Evidence for increased renal norepinephrine overflow during sodium restriction in humans. Hypertension 1990; 16:121-130.
138. 138 Andersson O, Persson B, Hedner T, Aurell M, Berglund G, Faberger B. Central haemodynamics, baroreceptor sensitivity and alpha-1 adrenoreceptor-mediated vascular reactivity during weight-stable sodium restriction in obese men with hypertension. J Hypertens 1986; 4:101-107.
139. 139 Luft FC, Raukin LI, Henry DP, Block R, Grim CG, Weyman AE, et al. Plasma and urinary values at extremes of sodium intake in normal man. Hypertension 1979; 1:261-266.
140. 140 Fagius J, Beme C. Increase in muscle sympathetic nerve activity in humans after food intake. Clin Sci 1994; 86:159-167.
141. 141 Cox HS, Kaye DM, Thompson JM, Turner AG, Jennings GL, Itsiopoulos C, et al. Regional sympathetic nervous activation after a large meal in humans. Clin Sci 1995; 89:145-154.
142. 142 Welle S, Liavivat U, Campbell RG. Thermic effect of feeding in man: increased plasma norepinephrine levels following glucose but not protein or fat consumption. Metab Clin Exp 1981; 30:953-958.
143. 143 Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycemic hyperinsulinemia. Evidence from microelectrode nerve recordings. Diabetologia 1992; 35:873-879.
144. 144 Berne C, Fagius J. Skin nerve sympathetic activity during insulin-induced hypoglycaemia. Diabetologia 1986; 29:855-860.
145. 145 Friberg P, Elam M, Gudjornsdottir S, Lonnroth P, Wallin BG. In patients with primary hypertension euglycemic hyperinsulinemia clamp does not change total or renal noradrenaline spillover [Abstract]. J Hypertens 1994; 12 (Suppl. 3):S186.
146. 146 Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta L, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous activity in normal man. Diabetes 1981; 30:219-225.
147. 147 Vissing SF, Hjortso EM. Central motor command activates sympathetic outflow to the cutaneous circulation in humans. J Physiol (Lond) 1996; 492:931-939.
148. 148 Tidgren B, Hjemdahl P. Reflex activation of renal nerves in humans: differential effects on noradrenaline, dopamine and renin overflow to renal venous plasma. Acta Physiol Scand 1988; 134:23-34.
149. 149 Wallin BG, Morlin C, Hjemdahl P. Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects. Acta Physiol Scand 1987; 129:489-497.
150. 150 Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J. Renal neurohumoral and vascular responses to dynamic exercise in humans. J Appl Physiol 1991; 70:2279-2286.
151. 151 Kotchen TA, Hartley LH, Rice TW, Mougey EH, Roy Jones L, Mason JW. Renin, norepinephrine and epinephrine responses to graded exercise. J Appl Physiol 1971; 31:178-184.
152. 152 Grassi G, Seravalle G, Calhoun DA, Mancia G. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension 1994; 23:294-301.
153. 153 Meredith IT, Friberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, et al. Regular exercise lowers renal but not cardiac sympathetic activity in man. Hypertension 1991; 18:575-582.
154. 154 Andersson B, Elam W, Wallin BG, Bjorntorp P, Andersson OK. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 1991; 18:783-789.
155. 155 Grassi G, Seravalle G, Colombo M, Bolla GB, Cattaneo BM, Cavagnini F, et al. Body weight reduction, sympathetic nerve traffic and arterial baroreflex in obese normotensive humans. Circulation 1998; 97:2037-2042.
156. 156 Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity and congestive heart failure. Hypertension 1998; 31:64-67.
157. 157 Middlekauff HR, Hamilton MA, Stevenson LW, Mark AL. Independent control of skin and muscle sympathetic nerve activity in patients with heart failure. Circulation 1994; 90:1794-1798.
158. 158 Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 1994; 23:570-578.
159. 159 Scherrer U, Randin D, Trappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89:2634-2640.
160. 160 Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler MD. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-3429.
161. 161 Andersson B, Wallin G, Hedner T, Ahlberg AC, Andersson OK. Acute effects of short-term fasting on blood pressure, circulating noradrenaline and efferent sympathetic nerve activity. Acta Med Scand 1988; 223:485-490.
162. 162 O'Dea K, Esler M, Leonard P, Stockigt J, Nestel P. Noradrenaline turnover during under-and over-eating in normal weight subjects. Metabolism 1982; 31:896-899.
163. 163 Young JB, Rosa RM, Landsberg L. Dissociation of sympathetic nervous system and adrenal medullary responses. Am J Physiol 1984; 247;E35-E40.
164. 164 Eisenhofer G, Friberg P, Goldstein DS, Esler M. Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. Br J Clin Pharmacol 1995; 40:263-265.
165. 165 Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell MA, Morris M, et al. Aging effects on human sympathetic neuronal function. Am J Physiol 1995; 268:R278-R285.
166. 166 Esler M, Kaye D, Thompson J, Jennings G, Cox G, Turner A, et al. Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. J Clin Endocrinol Metab 1995; 80:435-442.
167. 167 Swedberg KP, Eneroth J, Kiekshu S, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82:1730-1736.
168. 168 Esler M, Eisenhofer G, Chin J, Jennings G, Meredith I, Cox H, et al. Is adrenaline released by sympathetic nerves in man? Clin Auton Res 1991; 1:103-108.
169. 169 Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens 1994; 12:495-502.
170. 170 Packer M. Treatment of chronic heart failure. Lancet 1992; 340:92-95.